ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)
| 19.57 Data as of May 24 |  +0.13 / +0.67%Today’s Change | 15.13 Today|||52-Week Range 25.40 | +2.03% Year-to-Date |
Latest ARIA News | Press Releases
| 4 Health Care Stocks Spiking on Big Volume May 23 / TheStreet.com | Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Winner May 22 / TheStreet.com |
Today’s Trading
| Previous close | 19.44 |
| Today’s open | 19.43 |
| Day’s range | 19.09 - 19.75 |
| Volume | 2,652,526 |
| Average volume (3 months) | 3,129,720 |
| Market cap | $3.6B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -44.09% |
| Earnings growth (this year) | -21.87% |
| Earnings growth (next 5 years) | -7.20% |
| Revenue growth (last year) | -97.79% |
| P/E ratio | NM |
| Price/Sales | 5,670.27 |
| Price/Book | 28.97 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CBSTCubist Pharmaceutica... | -0.54 | -0.96% |
| PRXLPAREXEL Internationa... | -0.11 | -0.24% |
| ISISIsis Pharmaceuticals... | +0.34 | +1.65% |
| CRLCharles River Labora... | +0.04 | +0.09% |
Data as of 4:02pm ET, 05/24/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.40 |
| Annual revenue (last year) | $558.0K |
| Annual profit (last year) | -$220.9M |
| Net profit margin | -39,582.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Harvey J. Berger, MD |
Senior VP-Corporate Development & Operations Pierre F. Dodion, MD, MBA |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
